We were dead even last week and are now up .1% for the year. The DOW ended the week down .6% and NASDAQ was down 1.1%. For the year the DOW is down .4% and NASDAQ is up 2.9%.

DXM and MRVC earnings last week.

Some of our stocks are just stupid cheap—compared to their net cash on hand divided by their stock price.

Check this list:

UNTD

33%

CCUR

35%

SIGM

38%

MRVC

33%

SYNC

36%

CTIG

52%

PRSS

47%

AVID, ATEC, PRSS, SYNC, EXTR, and DXM can still be bought.

Last week we went 6 stocks up, 8 down and 1 even. Since inception we are now 66 stocks up and 22 down for a 75% winning percentage (80% is our target win %). Of our closed-out positions 60 have been winners and 13 have been losers for an 82% win percentage and a 35% average net gain per position.

The model portfolio assumes $10,000 invested in each stock (unless we double-up–then it is $20,000), less $10 commission each way (TD Ameritrade rate).

Avid Technology, Inc. (NASDAQ-AVID)-Recommended 1/20/2015)

Buy Price $14.00

Valuation $28.10

Closed down $1.07 at $14.63

Next earnings for Q4 2014 due out Tuesday, March 17th after the market close.

UP 5% HOLD

Alphatec Holdings, Inc. (NASDAQ-ATEC)-Recommended 9/2/2014)

Buy Price $1.56

Valuation $3.11 (Was $2.95, $3.00)

Closed down $.06 at $1.47

Q4 (12/31/2014) earnings were announced on February 26, 2015.

Revenues were $53.6 million compared to $53.1 million last year. EBITDA was up 22% from $7.5 to $8.3 million. 2015 guidance is revenues of $215 to $222 million and adjusted EBITDA of $34 to $37 million compared to 2014 revenues of $207 million and adjusted EBITDA of $30.8 million. Our valuation came in at $3.11 compared to the previous $2.95.

Boy, where do we start here. PRSS announced Q4 2014 earnings on February 25, 2015. Rather than focus on the actual results, because they include the results of the 2 divisions they are selling, we will focus on what we think the rest of 2015 looks like on a pro-forma basis (our best guess from the press release and conference call).

The sales of their two divisions will result in approximately $40 million of cash added to the $30 million or so at 12/31/2014. This will be just under $4 a share in net cash. The stock is trading below $4. The divisional sales will result in the loss of 35% of their revenues which were $230 million. So call it $150 million after the divestures. They had about $2.5 million of adjusted EBITDA in 2014 and from their conference call will lose some EBITDA as a result of the sales. So they may lose $1 million or so, on the EBITDA level in 2015. This does not concern us as that is nothing compared to $70 million in cash.

Looking at all this our valuation on a pro-forma basis comes in about $12.50 a share, and the company is much more focused on its’ core business, has its’ original management back that know how to run this business and are looking to build shareholder value.

Lloyd Miller filed a Form 13G on October 24, 2014 disclosing a 5.1% (887,000 shares) stake in PRSS..

Down 12% BUY

Extreme Networks, Inc. Inc. (NASDAQ-UNTD)-Recommended 3/12/2014)

Buy Price $3.43 (was $3.95 before we added another $10,000)

Valuation $9.34, (Was $8.24, $9.68, $8.52)

Closed down $.16 at $3.27

EXTR announced Q2, 2015 (December 31, 2014) earnings on January 28, 2015. Revenues were $147.2 million, up from $146.5 million last year. They made $4.7 million versus a $14.1 million profit last year on a Non-GAAP basis. Gross margin held steady at over 50%. Our valuation was $9.34 up from $8.34 last quarter. Cash per share was $.20 (compared to negative $.17 last quarter). Guidance for next quarter is a tepid $130-$140 million in revenue and bottom line of between a loss of $3.1 million and a profit of $1.8 million which will result in a valuation of about $8.40 a share (all Non-GAAP numbers). Hopefully they can beat this.

Down 5%, BUY

United Online Inc. (NASDAQ-UNTD)-Recommended 3/12/2014)

Buy Price $10.28

Valuation $34.65 (Was $33.50 $35.84, $32.35, $27.86)

Closed down $.02 at $17.00

UNTD announced Q4, 2014 (December 31, 2014) earnings after the close on February 18, 2015. Revenues were $54.4 million, down from $62.6 million last year, but up from $52.9 million last quarter. They made $2.3 million before tax versus an $8 million loss before taxes last year. Gross margin held steady at 68%. Our valuation was $34.65 up from $33.50 last quarter. Cash per share was $5.53 (compared to $5.38 last quarter). Guidance for next quarter is $47.5-$50.5 million in revenue and bottom line of between a loss of $.8 million and a profit of $2.8 million.

OIBTDA (which they use instead of EBITDA) was $11.4 million compared to $12.6 million last year.

Up 65% HOLD

Synacor Inc. (NASDAQ-SYNC)-Recommended 12/17/2013)

Buy Price $2.56

Valuation $6.61 (Was $5.58, $5.21, $5.44, $6.67, $6.39)’

Closed up $.07 at $2.35

Q4 earnings were announced on February 25, 2015. Actually they were surprisingly good and our valuation jumped to $6.61 a share. Then, they gave 2015 guidance of revenues of $95-100 million and EBITDA of $1.5 to $3.5 million—this would knock our valuation back down to about $5.29 a share. The CEO said they were “excited” about this-we are not. Revenues were $30.9 million for the quarter, up 18% over the previous quarter and up 5% over last year. Net cash rose to $.84 a share.

Pre-tax profit for the quarter was about $1 million versus $500,000 last year. EBITDA was $4 million compared to $2.8 million last year. Again, the quarter results were doused by 2015 tepid guidance.

DXM announced Q4 2014 (December 31, 2014) earnings on March 12th, 2015. http://finance.yahoo.com/news/dex-media-announces-fourth-quarter-110000000.html Revenues were $433 million, up from $429 million last year and down from $454 million last quarter and adjusted EBITDA was $173 million up from $167 million last quarter and down from $210 million last year. Overall an OK quarter. Our valuation stayed at $31.

Comparing the actual 2014 results to their original merger projections in 2012, as expected, they missed their revenue and EBITDA targets by $324 million and $121 million respectively. But more importantly they exceeded their debt reduction target by $200 million. They paid down another $73 million in net debt in Q4. We still think this is a BUY, albeit a risky stock due to the high debt levels and declining print advertising business.

DEX announced a major restructuring on December 11, 2014. They expect to incur

$70-$100 million of expenses to achieve $150 million of ongoing expense savings with $110 million of that coming in 2015. They expect to begin deleveraging their balance sheet (meaning Net Debt to adjusted EBITDA ratio) in 2016. No question that’s what they need to do.

Second quarter (10/31/2014) earnings announced on November 20th. Ouch!

Revenues were $5.7 million down from $7.9 million last year and down from $6.7 million last quarter. They lost $.06 on a GAAP basis compared to a $.05 loss last year. On a Non-GAAP basis they lost $.04 a share versus a profit of $.02 last year. Our valuation plunged to $1.83 from $2.83 last quarter. Net debt declined a bit to $7.6 million from $8.7 million last quarter and declined from $11.3 million a year ago. It will be a longer wait to see some action here. Still trading at less than 50% of our valuation but they need to get this company moving in the right direction-soon, or sell it.

Norm Pessin filed a 13D on November 27, 2013 disclosing a 6.2% stake and upped it to 12.2% in December 2013.

A five for 1 stock split coming, which was enough to offset the $1.8 million deal they signed last week

BLIN announced earnings on February 12, 2015 for Q4 2014. Not good. Revenues were down to $5 million from $6.5 million last year. They lost $2.1 million versus $.8 million last year. Looks like they were too occupied with their expense reductions in Q4.They did announce that they did not anticipate any more equity issuance in 2015, which is a good step. They reaffirmed their $800,000 a quarter expense reduction in 2015 also. All our hope is they can execute going forward on their record backlog going into 2015. Our valuation dropped to $1.17, still more than double the current trading price, but about 50% from where we started here. This is now a Hold—they need to show progress.

Not bad. Revenues were $93.3 million up 19% compared to $78.6 million last year and they made $.06 a share on an “adjusted basis” compared to $.02 last year. If this were some high flying tech stock this would be over $4 a share based on the 19% revenue jump-but alas, it is not. Apparently they “missed’ analysts revenue estimate and little happened with the stock price. Our valuation slid a bit to $6.55, up from $5.32 last year but down $.33 from last quarter.

They also reached a settlement with Becker Drapkin in February. BD gets two Board seats in exchange for not buying more than 12% of TSYS stock prior to 12/31/2016.

Becker Drapkin filed a 13D on November 24, 2014 disclosing a 6.7% stake. They had the standard 13D language about their intentions to discuss various options with management. Good news that someone is paying attention to this undervalued company.

We will continue to hold TSYS despite our over 100% gain. Maybe this will turn into another MITL and be trading at $10+ in the next year. .

MRVC announced Q4 2014 (December 31, 2014) earnings on March 10, 2015. http://finance.yahoo.com/news/mrv-reports-fourth-quarter-full-200500230.html Revenues were $43.4 million, up $200,000 from last quarter but down 14% from $50.7 million last year. They lost $2 million pre-tax versus a $.174 million loss last year. Net cash per share fell from last quarters $2.63 to $2.34 last quarter Our valuation was $24.44 down from $25.52 last quarter. They spent $3.2 million buying 307,000- shares in their share buyback program. Again, not sure this is the best use of their cash in that it just makes their loss per share bigger.

MRVC is trading at 32% of our valuation, but, we are moving this to a HOLD as sales growth has slowed, and losses have risen. Still cheap, but we are a bit wary.

Q3 2015 earnings were announced on December 10, 2014. Revenues were up 26% and they made $.04 a share on a Non-GAAP basis. Cash rose to $2.75 a share and our valuation jumped to $12.17 a share. Nice quarter-finally.

Ariel Investments filed a 13G on January 10, 2014 disclosing a 10.1% stake in Sigma.

CCUR announced Q2 2015 (December 31, 2014) earnings on January 27, 2015.. Revenues were $16 million, down 10% from $17.8 million last year. They lost $.6 million versus a $1.1 million profit last year. Gross margin held steady at 55%. Our valuation was $13.07 down from $14.80 last quarter. CCUR is trading at 52% of our valuation. Cash per share was $2.75 or 40% of the market cap. This is now a HOLD until we see what the new CEO can do and they get revenue growth back (and profits). We continue to collect the 7% dividend.

We have collected $1.08 in dividends so far (excluding the $.50 special dividend which reduced our basis).

ARI announced Q2 2015 earnings (quarter ended January 31, 2015) on March 5th. Revenues were $10.1 million up a whopping 25% over last year. They made a profit of $.02 per share versus a $.03 loss last year. Our valuation rose to $6.47 up from $5.96 last quarter. Recurring revenue was $9.1 million or 90% of total revenue. All in all, a very nice quarter.

They are doing a good job positioning the company to be acquired. Hopefully this will soon happen with a $5+ price like we got for XRS in September 2014.

UP 130%, HOLD, Still a large valuation gap here and the Company is executing well.

CTI announced last week that they had named their CFO as the Interim President and CEO. Having the CFO as CEO sometimes means they are ready to sell the company?

Q3 earnings announced after the close on November 14th when no one was looking. Results were actually good, so why are they hiding it? Another insider take-over bid coming? Revenues were up 14% to $4.1 million from $3.6 million last year and they lost $154,000 versus a loss of $384,000 last year. Adding back non-cash charges for amortization they made $273,000 pre-tax versus $129,000 last year. Cash increased from last quarter to $5.5 million from $5.3 million. They now have $.19 per share in cash. Our valuation rose to $1.34 per share, the highest in 2 years, CTIG is trading at 28% of our valuation.

John Birbeck announced his departure in October 2014. He was one of the group trying to take CTIG private for $.40 a share. Birbeck will remain a Director of the company. He owns about 7% of CTIG (about 2.3 million shares).

They need to get an investment banker and sell the company. Probably get at least $.75 a share for it from someone.